Pharmaceutical Biology (Dec 2023)

Saponins from Panax japonicus improve neuronal mitochondrial injury of aging rats

  • Cheng Fan,
  • Jin-Xin Wang,
  • Zhang-E. Xiong,
  • Shan-Shan Hu,
  • Ao-Jia Zhou,
  • Ding Yuan,
  • Chang-Cheng Zhang,
  • Zhi-Yong Zhou,
  • Ting Wang

DOI
https://doi.org/10.1080/13880209.2023.2244532
Journal volume & issue
Vol. 61, no. 1
pp. 1401 – 1412

Abstract

Read online

AbstractContext Panax japonicus is the dried rhizome of Panax japonicus C.A. Mey. (Araliaceae). Saponins from Panax japonicus (SPJ) exhibit anti-oxidative and anti-aging effects.Objective We evaluated the neuroprotective effects of SPJ on aging rats.Materials and methods Sprague-Dawley rats (18-months-old) were randomly divided into aging and SPJ groups (n = 8). Five-month-old rats were taken as the adult control (n = 8). The rats were fed a normal chow diet or the SPJ-containing diet (10 or 30 mg/kg) for 4 months. An in vitro model was established by d-galactose (d-Gal) in the SH-SY5Y cell line and pretreated with SPJ (25 and 50 µg/mL). The neuroprotection of SPJ was evaluated via Nissl staining, flow cytometry, transmission electron microscopy and Western blotting in vivo and in vitro.Results SPJ improved the neuronal degeneration and mitochondrial morphology that are associated with aging. Meanwhile, SPJ up-regulated the protein levels of mitofusin 2 (Mfn2) and optic atrophy 1 (Opa1) and down-regulated the protein level of dynamin-like protein 1 (Drp1) in the hippocampus of aging rats (p < 0.05 or p < 0.01 vs. 22 M). The in vitro studies also demonstrated that SPJ attenuated d-Gal-induced cell senescence concomitant with the improvement in mitochondrial function; SPJ, also up-regulated the Mfn2 and Opa1 protein levels, whereas the Drp1 protein level (p < 0.05 or p < 0.01 vs. d-Gal group) was down-regulated.Discussion and conclusions Further research on the elderly population will contribute to the development and utilization of SPJ for the treatment of neurodegenerative disorders.

Keywords